Ticker
GOSSCompany Name
GOSSAMER BIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow Yield | Market Capitalization |
---|---|---|---|
6/30/2025 | $ -154.38M | -31.43% | $ 491.14M |
3/31/2025 | $ 9.08M | 3.81% | $ 238.67M |
12/31/2024 | $ -3.47M | -1.17% | $ 295.39M |
9/30/2024 | $ -1.41M | -0.7% | $ 201M |
6/30/2024 | $ -3.87M | -2.15% | $ 179.85M |
3/31/2024 | $ -158.47M | -95.7% | $ 165.59M |
12/31/2023 | $ -159.16M | -48.66% | $ 327.09M |
9/30/2023 | $ -173.57M | -140% | $ 123.98M |
6/30/2023 | $ -176.1M | -64.06% | $ 274.89M |
3/31/2023 | $ -186.79M | -143.9% | $ 129.8M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Market Cap
(=) FCF Yield
FCF Yield for GOSSAMER BIO INC is calculated as follows: FCF [ $ -185.54M ] / Market Cap [ $ 703.09M ]
(=) FCF Yield [ -26.39% ]
Minimum
Dec 31, 2022
Maximum
Mar 31, 2025
Average
Median
filtered constituents | 3.58K |
---|---|
min | -33.87% |
max | 37.55% |
average | 1.59% |
median | 3.22% |
std | 11.38% |